CN108703365A - Protein allergy tailored version clinical nutrition formula and preparation method thereof - Google Patents
Protein allergy tailored version clinical nutrition formula and preparation method thereof Download PDFInfo
- Publication number
- CN108703365A CN108703365A CN201810445032.0A CN201810445032A CN108703365A CN 108703365 A CN108703365 A CN 108703365A CN 201810445032 A CN201810445032 A CN 201810445032A CN 108703365 A CN108703365 A CN 108703365A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- protein
- allergy
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010016946 Food allergy Diseases 0.000 title claims abstract description 65
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 59
- 230000035764 nutrition Effects 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000009472 formulation Methods 0.000 title claims description 18
- 235000018102 proteins Nutrition 0.000 claims abstract description 30
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 30
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 30
- 229940088594 vitamin Drugs 0.000 claims abstract description 30
- 229930003231 vitamin Natural products 0.000 claims abstract description 30
- 235000013343 vitamin Nutrition 0.000 claims abstract description 30
- 239000011782 vitamin Substances 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000002773 nucleotide Substances 0.000 claims abstract description 18
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 18
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 17
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 17
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 16
- 239000011573 trace mineral Substances 0.000 claims abstract description 14
- 235000013619 trace mineral Nutrition 0.000 claims abstract description 14
- 150000001413 amino acids Chemical class 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims description 75
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 34
- 235000019197 fats Nutrition 0.000 claims description 33
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 32
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 28
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 25
- 235000015097 nutrients Nutrition 0.000 claims description 25
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 24
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 20
- 230000007062 hydrolysis Effects 0.000 claims description 18
- 238000006460 hydrolysis reaction Methods 0.000 claims description 18
- 241000196324 Embryophyta Species 0.000 claims description 16
- 235000010469 Glycine max Nutrition 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 239000000839 emulsion Substances 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 235000005911 diet Nutrition 0.000 claims description 14
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 14
- 230000035622 drinking Effects 0.000 claims description 14
- 235000008216 herbs Nutrition 0.000 claims description 14
- 230000010354 integration Effects 0.000 claims description 14
- 229960003080 taurine Drugs 0.000 claims description 14
- 235000021342 arachidonic acid Nutrition 0.000 claims description 13
- 229940114079 arachidonic acid Drugs 0.000 claims description 13
- 230000037213 diet Effects 0.000 claims description 13
- 230000003301 hydrolyzing effect Effects 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 13
- 108090000942 Lactalbumin Proteins 0.000 claims description 12
- 102000004407 Lactalbumin Human genes 0.000 claims description 12
- 229920002774 Maltodextrin Polymers 0.000 claims description 12
- 239000005913 Maltodextrin Substances 0.000 claims description 12
- 239000004519 grease Substances 0.000 claims description 12
- 229940035034 maltodextrin Drugs 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- 108010038807 Oligopeptides Proteins 0.000 claims description 9
- 102000015636 Oligopeptides Human genes 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 8
- 240000000171 Crataegus monogyna Species 0.000 claims description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 8
- 235000004347 Perilla Nutrition 0.000 claims description 8
- 244000124853 Perilla frutescens Species 0.000 claims description 8
- 239000003240 coconut oil Substances 0.000 claims description 8
- 235000019864 coconut oil Nutrition 0.000 claims description 8
- 235000012907 honey Nutrition 0.000 claims description 8
- 239000004006 olive oil Substances 0.000 claims description 8
- 235000008390 olive oil Nutrition 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 239000003549 soybean oil Substances 0.000 claims description 8
- 235000012424 soybean oil Nutrition 0.000 claims description 8
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 8
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 8
- 240000007124 Brassica oleracea Species 0.000 claims description 7
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 7
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 7
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 7
- 241000206575 Chondrus crispus Species 0.000 claims description 7
- 241000207199 Citrus Species 0.000 claims description 7
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 7
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 7
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 7
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000011430 Malus pumila Nutrition 0.000 claims description 7
- 235000015103 Malus silvestris Nutrition 0.000 claims description 7
- 235000020971 citrus fruits Nutrition 0.000 claims description 7
- 230000001804 emulsifying effect Effects 0.000 claims description 7
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 7
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 6
- 241000251468 Actinopterygii Species 0.000 claims description 6
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims description 6
- 244000000626 Daucus carota Species 0.000 claims description 6
- 235000002767 Daucus carota Nutrition 0.000 claims description 6
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000011162 core material Substances 0.000 claims description 6
- 210000004317 gizzard Anatomy 0.000 claims description 6
- 235000012054 meals Nutrition 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 6
- 229920000053 polysorbate 80 Polymers 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 5
- 235000010489 acacia gum Nutrition 0.000 claims description 5
- 239000001785 acacia senegal l. willd gum Substances 0.000 claims description 5
- 239000008272 agar Substances 0.000 claims description 5
- 235000010419 agar Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 5
- 235000013339 cereals Nutrition 0.000 claims description 5
- -1 is uniformly mixed Substances 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 244000098338 Triticum aestivum Species 0.000 claims description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 4
- 229940100688 oral solution Drugs 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 235000019698 starch Nutrition 0.000 claims description 4
- 239000008107 starch Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 108090001030 Lipoproteins Proteins 0.000 claims description 3
- 102000004895 Lipoproteins Human genes 0.000 claims description 3
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 3
- 241000382353 Pupa Species 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229940029982 garlic powder Drugs 0.000 claims description 3
- KCYQMQGPYWZZNJ-BQYQJAHWSA-N hydron;2-[(e)-oct-1-enyl]butanedioate Chemical compound CCCCCC\C=C\C(C(O)=O)CC(O)=O KCYQMQGPYWZZNJ-BQYQJAHWSA-N 0.000 claims description 3
- GSSMIHQEWAQUPM-AOLPDKKJSA-N ovalbumin peptide Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CN=CN1 GSSMIHQEWAQUPM-AOLPDKKJSA-N 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 2
- 244000241838 Lycium barbarum Species 0.000 claims description 2
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 2
- 241000218231 Moraceae Species 0.000 claims description 2
- 235000008708 Morus alba Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 240000008866 Ziziphus nummularia Species 0.000 claims description 2
- 229940057917 medium chain triglycerides Drugs 0.000 claims description 2
- 235000013594 poultry meat Nutrition 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 244000291564 Allium cepa Species 0.000 claims 1
- 241000143060 Americamysis bahia Species 0.000 claims 1
- 241001251949 Xanthium sibiricum Species 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 235000019871 vegetable fat Nutrition 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 31
- 208000026935 allergic disease Diseases 0.000 abstract description 24
- 230000007815 allergy Effects 0.000 abstract description 24
- 208000024891 symptom Diseases 0.000 abstract description 18
- 235000021245 dietary protein Nutrition 0.000 abstract description 9
- 230000002708 enhancing effect Effects 0.000 abstract description 8
- 208000030961 allergic reaction Diseases 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 5
- 235000013350 formula milk Nutrition 0.000 description 43
- 239000003925 fat Substances 0.000 description 23
- 235000013305 food Nutrition 0.000 description 23
- 230000000694 effects Effects 0.000 description 16
- 238000011161 development Methods 0.000 description 15
- 230000018109 developmental process Effects 0.000 description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- 102000014171 Milk Proteins Human genes 0.000 description 10
- 108010011756 Milk Proteins Proteins 0.000 description 10
- 230000012010 growth Effects 0.000 description 10
- 235000021239 milk protein Nutrition 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 208000010668 atopic eczema Diseases 0.000 description 9
- 235000013336 milk Nutrition 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 6
- 229960001231 choline Drugs 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 229960000304 folic acid Drugs 0.000 description 6
- 235000019152 folic acid Nutrition 0.000 description 6
- 239000011724 folic acid Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 6
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 6
- 229960000367 inositol Drugs 0.000 description 6
- 229960003512 nicotinic acid Drugs 0.000 description 6
- 235000001968 nicotinic acid Nutrition 0.000 description 6
- 239000011664 nicotinic acid Substances 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 6
- 235000019155 vitamin A Nutrition 0.000 description 6
- 239000011719 vitamin A Substances 0.000 description 6
- 239000011691 vitamin B1 Substances 0.000 description 6
- 239000011715 vitamin B12 Substances 0.000 description 6
- 239000011716 vitamin B2 Substances 0.000 description 6
- 239000011647 vitamin D3 Substances 0.000 description 6
- 235000019165 vitamin E Nutrition 0.000 description 6
- 239000011709 vitamin E Substances 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 229940045997 vitamin a Drugs 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 241000234282 Allium Species 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 244000197580 Poria cocos Species 0.000 description 5
- 235000008599 Poria cocos Nutrition 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229960005069 calcium Drugs 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 229940091250 magnesium supplement Drugs 0.000 description 5
- 239000011572 manganese Substances 0.000 description 5
- 229910052748 manganese Inorganic materials 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000011772 phylloquinone Substances 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011726 vitamin B6 Substances 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000011632 Caseins Human genes 0.000 description 4
- 108010076119 Caseins Proteins 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 4
- 201000010859 Milk allergy Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 239000000605 aspartame Substances 0.000 description 4
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 4
- 229960003438 aspartame Drugs 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000005018 casein Substances 0.000 description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 4
- 235000021240 caseins Nutrition 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 235000021196 dietary intervention Nutrition 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 240000002234 Allium sativum Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 229920002752 Konjac Polymers 0.000 description 3
- 235000020616 amino acid formula Nutrition 0.000 description 3
- 235000003132 food thickener Nutrition 0.000 description 3
- 235000004611 garlic Nutrition 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 2
- 244000247812 Amorphophallus rivieri Species 0.000 description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 235000017060 Arachis glabrata Nutrition 0.000 description 2
- 244000105624 Arachis hypogaea Species 0.000 description 2
- 235000010777 Arachis hypogaea Nutrition 0.000 description 2
- 235000018262 Arachis monticola Nutrition 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000004262 Food Hypersensitivity Diseases 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002581 Glucomannan Polymers 0.000 description 2
- 102000008192 Lactoglobulins Human genes 0.000 description 2
- 108010060630 Lactoglobulins Proteins 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- 102000007079 Peptide Fragments Human genes 0.000 description 2
- 108010033276 Peptide Fragments Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 229920000294 Resistant starch Polymers 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 239000005862 Whey Substances 0.000 description 2
- 102000007544 Whey Proteins Human genes 0.000 description 2
- 108010046377 Whey Proteins Proteins 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 239000003659 bee venom Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 229940046240 glucomannan Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 239000000252 konjac Substances 0.000 description 2
- 235000010485 konjac Nutrition 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 235000020232 peanut Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000021254 resistant starch Nutrition 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SUVMJBTUFCVSAD-JTQLQIEISA-N 4-Methylsulfinylbutyl isothiocyanate Natural products C[S@](=O)CCCCN=C=S SUVMJBTUFCVSAD-JTQLQIEISA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 108010013043 Acetylesterase Proteins 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010021746 Infantile colic Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 108010055297 Sterol Esterase Proteins 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000017168 chlorine Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 235000004879 dioscorea Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 208000011318 facial edema Diseases 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000020985 infant symptom Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical group O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical group [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000005360 mashing Methods 0.000 description 1
- 230000006386 memory function Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical group 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000021085 polyunsaturated fats Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960004839 potassium iodide Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 210000004129 prosencephalon Anatomy 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 230000004491 retinal development Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 235000015487 sulforaphane Nutrition 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000005672 tetraenes Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The present invention provides a kind of protein allergy tailored version clinical nutrition formula, including following component and its parts by weight:15-21 parts of protein and amino acid, 11-15 parts of fat, 52-57 parts of carbohydrate, 3.4-4.2 parts of dietary fibers, 1.2-1.8 parts of macroelements, 0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.1-0.3 parts of water soluble vitamins, 0.005-0.11 parts of nucleotide, 0.02-0.06 parts of natural plants compounds;The present invention also provides the preparation methods of above-mentioned clinical nutrition formula.The present invention can improve patient body quality, enhancing immune function, Reduce allergy symptom, prevent food protein allergy crowd from allergic reaction occurs.
Description
Technical field
The present invention relates to nutrient formulation field more particularly to a kind of protein allergy tailored version clinical nutrition formula and its systems
Preparation Method.
Background technology
Numerous research reports point out that incidence is in continue ascendant trend to anaphylactia in recent years, and the incidence of allergy is
As the 6th of global disease, it has also become endanger a kind of common chronic disease of children's physical and mental health, the U.S. is used for every year
The medical expenses of children's allergy reach hundred million dollars of 2-4.
In numerous anaphylactias, food hypersenstivity is one of main inducement.Food hypersenstivity is body to intake
A kind of adverse immune reaction that food protein generates, food hypersenstivity have become public health problem of increasing concern, baby
Child's period since gastrointestinal tract is not yet reached maturity, immune system do not develop yet it is perfect, therefore be easy to occur food hypersenstivity, baby
Child's period food hypersenstivity incidence becomes apparent from higher than adult, and infant food allergy is easy to cause infantile colic, what is more
It can cause the general reaction of anaphylactic shock, it also occur that sudden death syndrome.
In numerous food hypersenstivities, protein allergy is one of most common food hypersenstivity.Easily leading to infantile allergy
Anaphylactogen in, main source has milk, soybean, wheat, peanut, nut and an egg, in protein allergies source therein predominantly
Milk protein and food proteins.There are mainly four types of main proteins, including beta lactoglobulin, gamma Globulin, lactoalbumin in milk
And casein, wherein beta lactoglobulin and casein is two common anaphylactogens.It, can after these anaphylactogens enter human organism
To be mediated by IgE, make mast cell sensitization and activate, discharges the substances such as a large amount of serotonin, slow sharp skin, it is more to occur
The allergic phenomena of organ and system;Can also be mediated by non-IgE, as acidophil mediate or the mediation of falling T cell to milk egg
It is white to generate serial allergic reaction, it can show as eczema, nettle rash, pruitus, lip, facial edema in skin;Digestive
System can show as nausea,vomiting,diarrhea or stool band blood, enterospasm, constipation, abdominal distension, difficulty with feeding etc.;Typical respiratory tract
Symptom includes rhiocnesmus, sneezing, runny nose, coughs, pants, hoarseness, and CMPA even can cause fatal larynx water compared with severe one
Swollen, asphyxia and anaphylactic shock;Part infant can cause malnutritive, anaemia and growth and development slow due to that cannot intervene in time
It is slow, therefore clarify a diagnosis and treat in early days and is extremely important.
In recent years, as people's lifestyle changes, significantly reducing children's exposed earlier microflora and cause of disease
The chance of body, so numerous easy milk protein allergy induced in protein allergy disease becomes infant food allergy
In one of most common protein allergy.It is shown according to related data, the incidence of children's milk protein allergy accounts for 2%- within 1 years old
7.5%.Atopic dermatitis is one of the major complications of milk protein allergy, shows as inflammatory, pruritic, recurring skin
Disease brings serious influence to the growth and development of children.Since most of regular convention formula milk powder are improved by cow's milk, cow's milk
Middle casein and lactalbumin antigenicity are stronger, are easy to cause baby and protein allergy reaction occurs.Breast-feeding helps to keep away
The intake for exempting from foreign protei reduces the occurrence risk of anaphylactia, but current Pure breast feeding to reduce sensibiligen quantity
It is less.
Foreign study, which shows to feed using hydrolyzed formulas milk powder when breast milk deficiency, can prevent the generation of anaphylactia,
But still there is the research of the allergy prevention effect of appropriate hydrolyzed formulas in the country pending.It is directed to milk protein allergy at present, it can be with
It gives amino acid formula milk or depth hydrolysis' formula milk or appropriate hydrolyzed formulas milk powder is fed, the therapeutic intervention time is with 3-12
It is advisable within a month.Amino acid formula milk is the antigenicity that milk protein is reduced to protein component by special processing, makes its end
Product is oligopeptides, has avoided the antigenicity of milk protein, and the fat containing normal amount and carbohydrate, nutrition completely
It is still constant, it is mainly used for the treatment of middle severe milk allergy infant;Depth hydrolysis' formula milk is to be by milk protein hydrolysate
Short peptide chain significantly reduces the antigenicity of lactalbumin and casein, is mainly used for the treatment of light moderate milk allergy infant;Part
The milk protein of hydrolyzed formulas milk powder is small peptide fragment, and hydrolysis degree is relatively low, and there are still incomplete antigen activity, are mainly used for preventing morning
The development of phase allergy and reduction allergy risk.
The method for the treatment of food hypersenstivity is to eliminate allergen and food preparation under a cloud in diet, is often referred in food
Protein, this be treat food hypersenstivity basis.Therefore, for the baby children for the milk allergy for being unable to get abundant breast-feeding
Youngster needs to substitute dairy products based on depth hydrolysis' albumen or amino acid formula.But hydrolyzing lactoalbumin formula currently on the market
Powder huge number, the degree of hydrolysis and peptide chain distribution situation for hydrolyzing lactoalbumin are irregular, give food protein allergy crowd
Bring some potential safety problems.
Chinese invention CN106072530A discloses a kind of anti-protein allergies full nutrition formula food, is formulated in albumen
Except matter, fat and carbohydrate, essential vitamin and minerals, added ferment powder, probiotics and prebiotic component,
Although it improves absorption problem of the protein allergy baby to protein, it is suitable that it is not directed to protein allergy baby addition
The special dietary substance of conjunction is to help baby to improve body quality, Reduce allergy symptom.
Therefore, developing prevents food protein allergy crowd from allergic reaction occurs, and can be according to needed for protein allergy crowd
Clinical nutrition feature, improve body quality, enhancing immune function, Reduce allergy symptom product, there is important value and wide
Wealthy market.
Invention content
The purpose of the present invention is to overcome the defects in the prior art, provides a kind of protein allergy tailored version clinical nutrition
Formula and preparation method thereof, the clinical nutrition feature needed for protein allergy crowd provide three balanced big nutrients
Matter also contains multivitamin and minerals, provides the nutrition of high quality, can improve body quality, enhancing immune function, delay
Solve allergic symptom;And give enteral battalion using hydrolyzed formulas milk powder such as depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumins
It supports and supports, prevent food protein allergy crowd from allergic reaction occurs.
To achieve the above object, the present invention adopts the following technical scheme that:
The first purpose of the invention is to provide a kind of protein allergy tailored version clinical nutrition formulas, including following component
And its parts by weight:15-21 parts of protein and amino acid, 11-15 portions of fat, 52-57 parts of carbohydrate, 3.4-4.2 portions of meals
Eat fiber, 1.2-1.8 parts of macroelements, 0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.1-
0.3 part of water soluble vitamin, 0.005-0.11 parts of nucleotide, 0.02-0.06 parts of natural plants compounds;
Wherein, the protein includes amino acid and protein peptides;The amino acid includes taurine, and the protein peptides are selected from
Depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumin, soy peptide powder, soybean oligopeptide, wheat protein peptide, pupa albumen peptide,
At least one of ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide;
Wherein, in the nutrient formulation, protein:Fat:The productivity ratio of carbohydrate is 15~20:25~35:50
~55.
In order to advanced optimize above-mentioned technical proposal, the technical measures that the present invention is taken further include:
Further, the protein peptides include in depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumin, soy peptide powder
It is at least one.
Further, in the nutrient formulation, protein:Fat:The productivity ratio of carbohydrate is 17: 30:53.
Further, the parts by weight of the taurine are 0.3-0.6 parts;Further, the weight of the taurine
Number is 0.36 part.
Further, the fat includes saturated fatty acid, polyunsaturated fatty acid, monounsaturated fatty acids, OPO knots
At least one of structure fat, DHA, EPA, ARA, phosphatide.Further, the fat includes docosahexaenoic acid and peanut
Tetraenoic acid, the weight ratio that the docosahexaenoic acid accounts for total fat is 1%~2%, and the arachidonic acid accounts for total fat
Weight ratio be 0.4%~2.4%;Further, the weight ratio that the docosahexaenoic acid accounts for total fat is 1%
~1.5%, the weight ratio that the arachidonic acid accounts for total fat is 0.4%~1%.
Further, in the fat, the ratio of ω -6 unsaturated fatty acids and omega-3 unsaturated fatty acid is 3~6:1
~2;Further, the ratio of ω -6 unsaturated fatty acids and omega-3 unsaturated fatty acid is 4:1.
Further, the carbohydrate is selected from least one of maltodextrin, tapioca, resistant starch.
Further, the dietary fiber is selected from inulin, konjaku flour, galactooligosaccharide, oligofructose, oligomeric different malt
At least one of sugar, soybean polyoses, cyclodextrin, resistant dextrin, soybean fiber.
Further, the macroelement is selected from calcium citrate, L-calcium lactate, calcium monohydrogen phosphate, calcium carbonate, potassium chloride, chlorine
Change at least one of sodium, magnesium carbonate, magnesium sulfate, K-IAO, sodium citrate and magnesium gluconate.
Further, the trace element is selected from ferrous gluconate, ferric pyrophosphate, potassium iodide, zinc gluconate, sub- selenium
At least one of sour sodium, copper gluconate, copper sulphate, manganese sulfate, chromium chloride, chromium sulfate, manganese gluconate and sodium molybdate.
Further, the liposoluble vitamin is selected from vitamin A, beta carotene, vitamin D3, vitamin E, dimension life
Plain K1At least one of.
Further, the water soluble vitamin is selected from vitamin B1, vitamin B2, vitamin B6, vitamin B12, dimension life
At least one of plain C, pantothenic acid, folic acid, niacin, choline, inositol, biotin.
Further, the parts by weight of the nucleotide are 0.11-1.2 parts;Further, the weight of the nucleotide
Number is 0.11 part;Further, the nucleotide is 5'Monophosphate cytidine.
Further, the natural plants compound is selected from l-cn, Glucosamine, oligofructose, lutein, plant
At least one of object sterol, lycopene, resveratrol, allicin;More preferably l-cn.
Further, the protein allergy tailored version clinical nutrition formula further includes 0.1-1 parts of integration of drinking and medicinal herbs ingredients, institute
Integration of drinking and medicinal herbs ingredient is stated in hawthorn, the membrane of a chicken's gizzard, mulberries, matrimony vine, fructus alpiniae oxyphyllae, Chinese yam, Poria cocos, malt, honey, jujube extremely
Few one kind;Further, the integration of drinking and medicinal herbs ingredient is hawthorn, the membrane of a chicken's gizzard, Chinese yam, Poria cocos, honey.
Further, the protein allergy tailored version clinical nutrition formula further includes 0.1-1 parts of diet essence, the meals
Essence is eaten in cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fish and shrimp, poultry meat, fruits
It is at least one;Wherein, the greengrocery includes carrot meal, onion powder, garlic powder, cabbage powder, and the Homonemeae includes needle mushroom
Powder, the fruits include citrus powder, apple powder.
Second object of the present invention is to provide a kind of dry method work of above-mentioned protein allergy tailored version clinical nutrition formula
The preparation method of skill, includes the following steps:
Step 1, powder fat is prepared;
Step 2, liposoluble vitamin powder and water soluble vitamin powder are prepared:By the fat-soluble dimension of predetermined weight number
Raw element is used as core material, selects carragheen, Arabic gum as wall material, carries out 2 emulsifying homogeneous processing, emulsifying homogeneous under high pressure
Time is 10~15min, then carries out instantaneous drying of spraying, liposoluble vitamin powder is prepared with 60~80 mesh screenings;It will be pre-
The water soluble vitamin of parts by weight is determined as core material, is selected maltodextrin, lipoprotein as wall material, is uniformly mixed, sprays wink
When dry, prepare water soluble vitamin powder with 60~80 mesh screenings;
Step 3, by the protein of predetermined weight and amino acid, nucleotide, carbohydrate, dietary fiber, macroelement,
Trace element, natural plants compound are prepared into the powder that grain size is 150~250 μm respectively;
Step 4, the mixing machine that the powder obtained by step 1~3 is sequentially added to cone-type mixer or other forms mixes
Uniformly obtained formula mixture, it is spare after sterilization processing;
Step 5, the formula mixture is prepared into nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution
At least one of;
Wherein, the sequence of step 1~3 can be replaced mutually.
Further, powder fat is prepared in the step 1 to specifically comprise the following steps:
1) wall material aqueous solution is prepared:Take maltodextrin 273g, octenyl succinic acid starch 44g, lactalbumin 186g, diet
Fiber 80g, water 1L are stirred evenly;It can be heated while stirring when having ready conditions to 60 DEG C, keep 30 minutes postcoolings to room temperature;
2) monoglyceride is taken into 1.17g (a concentration of 0.2%) of total solid is uniformly dissolved in 15.6mL mixed plant greases;Institute
State mixed plant grease by 3mL olive oil, 6mL soybean oils, 3mL coconut oil, 0.8mL perilla herb oils, 2.5mL medium chain triglycerides,
0.2mL docosahexaenoic acid greases, 0.1mL arachidonic acid oils composition;
3) Tween 80 is taken into 1.17g (a concentration of 0.2%) of total solid is uniformly dissolved in the wall material aqueous solution;
4) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed, obtains mixed solution;
5) addition stabilizer agar takes 1.17g (a concentration of 0.2%) of total solid after the mixed solution, with water constant volume
To 200mL, (a concentration of 25%) of total solid, high speed dispersion 2 minutes, obtains emulsion under 20000r/min;
6) by the emulsion at homogenization pressure 25MPa, homogeneous 3 times 5 minutes every time, obtains homogeneous emulsion;
7) the homogeneous emulsion is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C, is collected
To powder fat.
Further, can also include the following steps between the step 3 and step 4:
Prepare integration of drinking and medicinal herbs component powders:The raw material of predetermined weight number is crushed using pulverizer, by crushing
Raw material is placed in container, be added weight be raw material weight 3~8 times of water, carry out immersion 3~4 hours, then to soak into
Row decocts 30~60min, and filtering removal raw material is left and taken decoction liquor, is spray-dried to decoction liquor, sieved and made with 60~80 mesh
Standby integration of drinking and medicinal herbs component powders.The step can mutually be replaced with the sequence of step 1~3.
Prepare diet essence powder:By carrot, onion, garlic, cabbage, needle mushroom, citrus, apple respectively using mashing
Machine breaks into mixing after juice, crosses 120 mesh sieve, is added after resistant starch, isomalto-oligosaccharide fully by the 20~30% of reduction of feed volume
Stirring and dissolving obtains mixed serum, at homogenization pressure 25MPa, to mixed serum homogeneous 3 times, and 5 minutes every time, then to homogeneous
Liquid sterilize and is dried using press spray drier, and diet essence powder is prepared with the screening of 80~100 mesh.
The step can mutually be replaced with the sequence of step 1~3.
Wherein, optionally increase suitable food thickening agent and food additives in the step 5.The food increases
Thick dose in guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum at least one
Kind;The food additives are selected from least one of Aspartame, food flavor fragrance, brown sugar.More preferably carragheen, Ah
Draw primary glue, guar gum, Aspartame, food flavor fragrance.
Further, the operation step of the preparation method of the dry process of above-mentioned protein allergy tailored version clinical nutrition formula
Suddenly it is both needed to carry out under the protection of inert gas, used inert gas is nitrogen, argon gas, helium etc..In inert gas
The lower progress aforesaid operations step of protection can prevent the danger of powder explosion.
In addition, the present invention also provides a kind of preparations of the wet processing of above-mentioned protein allergy tailored version clinical nutrition formula
Method includes the following steps:
Step 1, by the protein of predetermined weight number and amino acid, fat, carbohydrate, dietary fiber, constant member
Element, trace element, liposoluble vitamin, water soluble vitamin, nucleotide, natural plants compound are pressed in the water of predetermined amount
It according to the physical behavior of raw material, adds according to sequencing, is stirred while addition successively, the mixing breast of raw material is made
Liquid;
Step 2, mixed emulsion step 1 obtained carries out emulsifying homogeneous, concentrating sterilizing, obtains concentrate;
Step 3, the concentrate that step 2 obtains is spray-dried, is sieved, is prepared into powder, is prepared by the powder
At at least one of nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution.
In the present invention using include hawthorn, the membrane of a chicken's gizzard, Chinese yam, Poria cocos, honey integration of drinking and medicinal herbs ingredient, mentioned component compatibility
After synergy have stomach strengthening and digestion promoting, enhancing body resistance against diseases the benefits of, which improve conventional nutraceutical formula often make baby generate flatulence,
It the digestive problems such as is not easy to absorb, peomotes the absorption of each nutriment in nutrient formulation, enhance baby's constitution, accelerate baby children
The growth and development of youngster.
Hawthorn can promote gastric secretion to help digest, and have good functions of strengthening stomach and promoting digestion;The lipolytic enzyme contained in hawthorn
There is good digestion for the food of fats, can effectively promote the secretion of gastric juice in body, improve digestible energy
Power;
The membrane of a chicken's gizzard has effects that food digesting stomach fortifying, and can be with invigorating the spleen and stomach, with hawthorn with can further enhance digestion-promoting
Long-pending effect;
Chinese yam is conducive to taste digestion and absorption function, and it is the work of glucose that the amylase contained by Chinese yam, which has hydrolysis starch,
With directly capable of providing thermal energy for brain, play an important roll to brain tonic;Nutritive yam is abundant simultaneously, has enhancing nerve thin
Cytoactive, bushing gas, tranquilizing mind control forgetful, nourishing heart intelligence development, enhance memory function;
Poria cocos can increase the cytotoxic effect of macrophage, increase nonspecific acid esterase positive lymphocyte number,
Enhance the cytotoxicity of T lymphocytes, mouse serum complement number can be remarkably reinforced in methylol pachymaran and special
Antigen-binding cells number, have the function of enhance body's immunity;
Honey is regarded as a kind of food and drug full of nutrition since ancient times, there is anti-inflammatory, eliminating the phlegm, moistening lung, cough-relieving
The effect of, it takes for a long time, the breaking-out of asthma can also be alleviated;Honey can also be pre- hypo-allergenic simultaneously;Also contain inside honey
Micro bee venom, it is a kind of toxic liquid in honeybee body, and bee venom has corticotropin sample effect, can improve human body
Interior ambient condition adjusts immunity of organisms, has the function of antiallergy, radioresistance, enhancing body resistance against diseases.
In the present invention using include carrot, onion, needle mushroom, garlic, citrus, cabbage, apple diet essential ingredient,
There is the benefits of Reduce allergy symptom, prevention of inflammation after mentioned component compatibility synergy, may go out for protein allergy infant
Existing allergic symptom plays effective prevention and mitigation, improves the body quality of baby, contribute to the growth of baby
Development.
Contain a large amount of anti-inflammatory, antiallergy substance in carrot, onion, needle mushroom, garlic, it being capable of effective pre- pollen-proof
The allergic reactions such as allergy, allergic dermatitis;
Citrus can reconcile stomach, and stimulating intestine and stomach is wriggled, and helps to be vented, moreover it is possible to which calm alimentary canal increases appetite, stimulation food
It is intended to;Vitamin C is rich in citrus, vitamin C can inhibit the generation of histamine in vivo, and can improve capillary permeability,
The exudation for reducing tissue fluid, to Reduce allergy symptom;
The Quercetin that cabbage is rich in can effectively prevent allergy and asthma, have anti-inflammatory and antihistamine characteristic;Flower simultaneously
Cabbage sprout contains abundant sulforaphane, is a kind of potent anti-inflammatory compound, has in terms of stimulating Antioxidation reaction
Apparent biological effect, the quantity that the cauliflower sprout of test dose can result in glutathione sulfydryl transferase doubles, this
Enzyme plays the role of antioxidant in human body, being capable of effective prevention of asthma, allergy and chronic obstructive pulmonary disease;
The Quercetin that apple is rich in can effectively prevent allergy and asthma, have anti-inflammatory and antihistamine characteristic;In apple
Polyphenol can by mitigate allergy mouse ear swelling and atopy patient scytitis by inhibition is played to histamine
Effect, contributes to the alleviation of protein allergy symptom.
The present invention is had the following technical effect that compared with prior art using above-mentioned technical proposal:
1) protein allergy tailored version clinical nutrition formula of the invention uses depth hydrolysis' albumen, and depth hydrolysis' albumen is not
Only dissolubility is good, and digestibility is high, acidproof, heat-resisting, equally also has a variety of physiological regulation functions, as blood pressure lowering, drop courage are solid
Alcohol, antibacterial, anticancer etc., albumen are superfine small segment by depth hydrolysis, significantly reduce the anaphylactoid risk of triggering, mainly
Treatment for light moderate milk allergy infant;Using appropriate hydrolyzing lactoalbumin, albumen is moderately hydrolyzed to small peptide fragment, mainly
Development for preventing early stage allergy and reduction allergy risk.
2) present invention addition 4:1 ω -6 unsaturated fatty acids and omega-3 unsaturated fatty acid, polyunsaturated fatty acid close
Reason proportioning, participates in phosphatide synthesis, cholesterol metabolic, the reparation of injury tissue, the growth of cambium, protects the skin from ray
Damage, plays an important roll brain, nerve fiber and retinal development, participates in hormone sensitive lipase gene, has protection to angiocardiopathy
Effect.
3) docosahexaenoic acid and arachidonic acid of present invention addition rational proportion, in the growth and development of baby,
Polyunsaturated fat has important structure and function, such as arachidonic acid (C20-4, n-6, ARA) and DHA, they are in breast milk
In it is naturally occurring in phospholipid form;ARA and DHA has actively impact to the development of brain and newborn's retina;In adult,
ARA and DHA can be synthesized by linoleic acid and alpha-linolenic acid, but the synthesis capability of baby is limited;DHA and ARA is from utero to going out
Continue to increase in baby's forebrain within 2 years old after life, is accumulated in fetal brain since 26th week pregnant, to 3 months thirds trimester of pregnancy
In continue;Since 1 years old~3 years old child is in the peak period of growth and development, add DHA and ARA, for infant's intelligence and
The development of physique is particularly important.
4) 0.11-1.2 parts of nucleotide of present invention addition, it is possible to reduce the generation of diarrhea, while increasing immunity of organisms, make
Fat, trace element are more easy to absorb.
5) present invention strengthens 0.3-0.6 parts of taurine, and the entitled 2-aminoethanesulfonic acid of taurine chemistry is cysteine through de-
Sulphur is simultaneously oxidized to sulfonate radical and a kind of derivative beta-amino sulfonic acid by carboxyl;The biological action of taurine includes combining bile
Normal development etc. that is sour, anti-oxidant and participating in brain and retina.
Nutrient refers to providing energy to human body in food, participating in body composition and the chemical composition of regulation of physiological functions,
Nutrition necessary to human body is known as protein, lipid, carbohydrate, minerals, vitamin, water, dietary fiber etc..The albumen of the present invention
Matter allergy tailored version clinical nutrition formula not only contains balanced three major nutrient, also contains multivitamin and minerals,
It is capable of providing high quality nutrition, enhances immune function, and using water such as depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumins
Solution formula milk gives EN support, is free of lactose, removes milk protein anaphylactogen, prevents food protein allergy crowd from sending out
Raw allergic reaction is protein allergy crowd, and comprehensively sufficient nutrition branch is provided especially for the infant of protein allergy
It holds, promotes the growth and development of infant.
The present invention is added by selecting the basal nutrient element of rational proportion with stomach strengthening and digestion promoting, enhancing body disease-resistant
The spies such as ability, Reduce allergy symptom, the dietary fiber of prevention of inflammation, natural plants compound, integration of drinking and medicinal herbs ingredient, diet essence
Different nutriment, and adjust its proportioning and carry out compatibility synergy with basal nutrient element, the protein allergy tailored version of the present invention made
Clinical nutrition formula is easier to be absorbed by protein allergy crowd, the effect of to give full play to each component, according to protein mistake
Clinical nutrition feature needed for quick crowd, the especially infant of protein allergy provide the nutritional support of comprehensive abundance for it,
Promote intelligence and anthropometic, improve body quality, Reduce allergy symptom.
Specific implementation mode
The present invention provides a kind of protein allergy tailored version clinical nutrition formulas comprising following component and its parts by weight
Number:15-21 parts of protein and amino acid, 11-15 parts of fat, 52-57 parts of carbohydrate, 3.4-4.2 parts of dietary fibers,
1.2-1.8 parts of macroelements, 0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.1-0.3 parts it is water-soluble
Property vitamin, 0.005-0.11 parts of nucleotide, 0.02-0.06 parts of natural plants compounds;
Wherein, in the nutrient formulation, protein:Fat:The productivity ratio of carbohydrate is 15~20:25~35:50
~55;
Wherein, the protein includes amino acid and protein peptides;The amino acid includes taurine, and the protein peptides are selected from
Depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumin, soy peptide powder, soybean oligopeptide, wheat protein peptide, pupa albumen peptide,
At least one of ocean fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide.
With reference to embodiment, the specific embodiment of the present invention is further described.Following embodiment is only used for more
Add and clearly demonstrate technical scheme of the present invention, and not intended to limit the protection scope of the present invention.
Embodiment 1
Protein allergy tailored version clinical nutrition formula of the present invention includes depth hydrolysis' PURE WHEY
20.02g, soy peptide powder 0.5g, taurine 0.36g;Nucleotide 0.11g;Olive oil 2.67g, soybean oil 5.35g, coconut oil
2.67g, perilla herb oil 0.76g, medium chain triglyceride 2.29g, docosahexaenoic acid grease 0.18g, arachidonic acid oil
0.064g;Maltodextrin 56.75g;Dietary fiber 3.66g;Calcium 0.51g, phosphorus 0.272g, potassium 0.485g, sodium in macroelement
0.291g, magnesium 0.157g;Iron 0.011g, zinc 0.007g, iodine 0.042mg, selenium 0.015mg, copper 0.154mg, manganese in trace element
0.18mg;Vitamin A 0.0007g, vitamin D30.0068mg, vitamin E 0.009g, vitamin K10.045mg;Vitamin
B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12It is 0.0018mg, vitamin C 0.142g, general
Sour 0.003g, folic acid 0.036mg, niacin 0.0027g, choline 0.055g, inositol 0.036g;L-cn 0.036g.
Embodiment 2
Protein allergy tailored version clinical nutrition formula of the present invention includes appropriate hydrolyzing lactoalbumin powder
20.02g, soy peptide powder 0.5g, taurine 0.36g;Nucleotide 0.11g;Olive oil 2.67g, soybean oil 5.35g, coconut oil
2.67g, perilla herb oil 0.76g, medium chain triglyceride 2.29g, docosahexaenoic acid grease 0.18g, arachidonic acid oil
0.064g;Maltodextrin 56.75g;Dietary fiber 3.66g;Calcium 0.51g, phosphorus 0.272g, potassium 0.485g, sodium in macroelement
0.291g, magnesium 0.157g;Iron 0.011g, zinc 0.007g, iodine 0.042mg, selenium 0.015mg, copper 0.154mg, manganese in trace element
0.18mg;Vitamin A 0.0007g, vitamin D30.0068mg, vitamin E 0.009g, vitamin K10.045mg;Vitamin
B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12It is 0.0018mg, vitamin C 0.142g, general
Sour 0.003g, folic acid 0.036mg, niacin 0.0027g, choline 0.055g, inositol 0.036g;L-cn 0.036g.
Embodiment 3
Protein allergy tailored version clinical nutrition formula of the present invention includes soy peptide powder 20.52g, taurine
0.36g;Nucleotide 0.11g, olive oil 2.67g, soybean oil 5.35g, coconut oil 2.67g, perilla herb oil 0.76g, medium chain triglyceride three
Ester 2.29g, docosahexaenoic acid grease 0.18g, arachidonic acid oil 0.064g;Maltodextrin 56.75g;Dietary fiber
3.66g;Calcium 0.51g, phosphorus 0.272g, potassium 0.485g, sodium 0.291g, magnesium 0.157g in macroelement;Iron in trace element
0.011g, zinc 0.007g, iodine 0.042mg, selenium 0.015mg, copper 0.154mg, manganese 0.18mg;Vitamin A 0.0007g, vitamin
D30.0068mg, vitamin E 0.009g, vitamin K10.045mg;Vitamin B10.001g, vitamin B20.001g, dimension
Raw element B60.001g, vitamin B120.0018mg, vitamin C 0.142g, pantothenic acid 0.003g, folic acid 0.036mg, niacin
0.0027g, choline 0.055g, inositol 0.036g;L-cn 0.036g.
Embodiment 4
Protein allergy tailored version clinical nutrition formula of the present invention includes depth hydrolysis' PURE WHEY
20.02g, soy peptide powder 0.5g, taurine 0.36g;Nucleotide 0.11g, olive oil 2.67g, soybean oil 5.35g, coconut oil
2.67g, perilla herb oil 0.76g, medium chain triglyceride 2.29g, docosahexaenoic acid grease 0.18g, arachidonic acid oil
0.064g;Maltodextrin 56.75g;Dietary fiber 3.66g;Calcium 0.51g, phosphorus 0.272g, potassium 0.485g, sodium in macroelement
0.291g, magnesium 0.157g;Iron 0.011g, zinc 0.007g, iodine 0.042mg, selenium 0.015mg, copper 0.154mg, manganese in trace element
0.18mg;Vitamin A 0.0007g, vitamin D30.0068mg, vitamin E 0.009g, vitamin K10.045mg;Vitamin
B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12It is 0.0018mg, vitamin C 0.142g, general
Sour 0.003g, folic acid 0.036mg, niacin 0.0027g, choline 0.055g, inositol 0.036g;L-cn 0.036g;Hawthorn
0.1g, the membrane of a chicken's gizzard 0.1g, Chinese yam 0.1g, Poria cocos 0.1g, honey 0.1g;Carrot meal 0.1g, onion powder 0.1g, garlic powder 0.1g,
Cabbage powder 0.1g, golden needle fungus 0.1g, citrus powder 0.1g, apple powder 0.1g.
Embodiment 5
Protein allergy tailored version clinical nutrition formula of the present invention includes depth ocean fish oligopeptide powder
20.02g, soybean oligopeptide 0.5g, taurine 0.36g;Nucleotide 0.11g;Olive oil 2.67g, soybean oil 5.35g, coconut oil
2.67g, perilla herb oil 0.76g, medium chain triglyceride 2.29g, docosahexaenoic acid grease 0.18g, arachidonic acid oil
0.064g;Maltodextrin 56.75g;Dietary fiber 3.66g;Calcium 0.51g, phosphorus 0.272g, potassium 0.485g, sodium in macroelement
0.291g, magnesium 0.157g;Iron 0.011g, zinc 0.007g, iodine 0.042mg, selenium 0.015mg, copper 0.154mg, manganese in trace element
0.18mg;Vitamin A 0.0007g, vitamin D30.0068mg, vitamin E 0.009g, vitamin K10.045mg;Vitamin
B10.001g, vitamin B20.001g, vitamin B60.001g, vitamin B12It is 0.0018mg, vitamin C 0.142g, general
Sour 0.003g, folic acid 0.036mg, niacin 0.0027g, choline 0.055g, inositol 0.036g;L-cn 0.036g.
Embodiment 6
A kind of preparation method of protein allergy tailored version clinical nutrition formula as described in 1~embodiment of embodiment 5 is such as
Under:
1) powdered oil (powder fat) is prepared:
A) wall material aqueous solution is prepared:Take maltodextrin 273g, octenyl succinic acid starch 44g, lactalbumin 186g, meals
Food fiber 80g, water 1L are stirred evenly and (are had ready conditions and heat while stirring to 60 DEG C, keep 30 minutes postcoolings to room temperature).
B) by monoglyceride take 1.17g (a concentration of 0.2%) of total solid be uniformly dissolved in 15.6mL greases (olive oil 3mL,
Soybean oil 6mL, coconut oil 3mL, perilla herb oil 0.8mL, medium chain triglyceride 2.5mL, docosahexaenoic acid grease 0.2mL, flower
Raw tetraene acid lipid 0.1mL).
C) Tween 80 is taken into 1.17g (a concentration of 0.2%) of total solid is uniformly dissolved in wall material aqueous solution.
D) the wall material aqueous solution of the mixed plant grease and addition Over emulsfication agent Tween 80 of Over emulsfication agent monoglyceride will be added
It is sufficiently mixed.
E) addition stabilizer agar takes 1.17g (a concentration of 0.2%) of total solid is settled into after mixed solution with water
200mL (a concentration of 25%) of total solid, high speed dispersion 2 minutes under 20000r/min.
F) homogenization pressure is 25MPa, and homogeneous emulsion is made in homogeneous 3 times (every time 5 minutes).
G) emulsion obtained is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C.Collect powder
Grease (powder fat).
2) integration of drinking and medicinal herbs component powders are prepared:The raw material of predetermined weight number is crushed using pulverizer, will be crushed
Raw material be placed in container, be added weight be raw material weight 3~8 times of water, immersion is carried out 3~4 hours, then to soak
30~60min of decoction is carried out, filtering removal raw material is left and taken decoction liquor, is spray-dried to decoction liquor, sieved with 60~80 mesh
Prepare integration of drinking and medicinal herbs component powders;
3) vitamin powder is prepared:Using the liposoluble vitamin of predetermined weight number as core material, select carragheen, I
Primary glue carries out 2 emulsifying homogeneous processing, the emulsifying homogeneous time is 10~15min, is then sprayed under high pressure as wall material
Mist is instantaneously dried, and liposoluble vitamin powder is prepared with 60~80 mesh screenings;The water soluble vitamin of predetermined weight number is made
It for core material, selects maltodextrin, lipoprotein as wall material, is uniformly mixed, spray instantaneous dry, water is prepared with 60~80 mesh screenings
Soluble vitamin powder;
4) by the protein of predetermined weight and amino acid, small peptide, nucleotide, carbohydrate, dietary fiber, constant member
Element, trace element, natural plants compound are prepared into the powder that grain size is 150~250 μm respectively;
5) mixing machine that the powder obtained by step 1)~step 4) is sequentially added to cone-type mixer or other forms is mixed
Uniformly obtained formula mixture is closed, it is spare after sterilization processing;
6) according to conventional technical means by the formula mixture in step 5) be prepared into nutrient powder, nutrition emulsion, capsule,
At least one of tablet, pill or oral solution.
In step 6), optionally increase suitable food thickening agent and food additives.The food thickening agent
It is described at least one of guar gum, xanthans, locust bean gum, konjac glucomannan, pectin, carragheen, agar, gelatin, Arabic gum
Food additives are at least one of Aspartame, food flavor fragrance, brown sugar;More preferable carragheen, Arabic gum, Guar
Glue, Aspartame, food flavor fragrance.
Aforesaid operations step is both needed to carry out under the protection of inert gas, such as nitrogen, argon gas, helium etc., to prevent from producing
The danger of green powder explosion.
According to described with the classifications such as powdery, graininess, capsule shape, tablet shape, beverage can be prepared into.
Embodiment 7
The present embodiment is verification embodiment.
This verification embodiment verifies protein allergy tailored version clinical nutrition formula of the present invention to protein allergy
The influence of patient.Electuary and following comparative example of the present embodiment using the formula preparation of embodiment 1,4 and 5:
Control group:The full nutritional formula milk powder of the commercially available anti-protein allergies of tradition;
Experimental group 1:The electuary prepared using the nutrient formulation of embodiment 1;
Experimental group 2:The electuary prepared using the nutrient formulation of embodiment 4;
Experimental group 3:The electuary prepared using the nutrient formulation of embodiment 5;
Experimental group 4:The electuary prepared using nucleotide is deleted in the nutrient formulation of embodiment 1;
Experimental group 5:The electuary prepared using diet essence is deleted in the nutrient formulation of embodiment 4;
Experimental group 6:The electuary prepared using integration of drinking and medicinal herbs ingredient is deleted in the nutrient formulation of embodiment 4;
The protein allergy infant 30 of corresponding electuary is voluntarily taken in every group of selection above, and severity extent is similar.Root
Above-mentioned electuary is given according to the age and corresponding situation of infant to feed, other diatery supplement etc. are given situation and remained unchanged.Nutrition is dry
The pre- time is 3 months total, observes and count the difference of the symptom of digestive tract and curative effect before and after infant nutritional intervention.Experimental result is such as
Shown in following table:
Table one is that the symptom of digestive tract of Different Nutrition patients before and after intervention infant compares.
Table two is the comparison of Different Nutrition patients before and after intervention curative effect.The criterion of wherein curative effect is:(1) effective:Nutrition is dry
The daily diarrhea of prognosis reduces to two days hereinafter, stool restores, and eczema mitigates, and skin lesion recession area is higher than 80%, clinical manifestation
It completely disappears, infant weight obviously increases.(2) effectively:Daily diarrhea number is reduced to less than 4 times after nutritional intervention, and moisture is bright
Aobvious to reduce, infant weight is without obviously increasing;Eczema skin lesion area recession 30%-80%, clinical manifestation disappear substantially, infant weight
Nothing obviously increases.(3) invalid:Infant symptom of diarrhea is without alleviation after nutritional intervention, and skin lesion area, which subsides, is less than 30%, original clinic
Symptom, sign are without improvement, infant weight loss.
The symptom of digestive tract of one Different Nutrition patients before and after intervention infant of table compares (example (%))
As seen from the above table, protein allergy tailored version clinical nutrition formula of the invention, compared to the commercially available anti-albumen of tradition
The full nutrient formulation of allergy, after intervening 3 months, the symptom of digestive tract of the vomiting of infant, diarrhea and constipation is significantly improved.Addition
Diet essence of the present invention and the experimental result of experimental group of integration of drinking and medicinal herbs ingredient its effect become apparent.
The comparison (example (%)) of the effect of two nutritional intervention time of table
Group | Number of cases | It is effective | Effectively | In vain |
Control group | 30 | 18 (60.0%) | 6 (20.0%) | 6 (20.0%) |
Experimental group 1 | 30 | 21 (70.0%) | 7 (23.3%) | 2 (6.7%) |
Experimental group 2 | 30 | 26 (86.7%) | 4 (13.3%) | 0 (0.0%) |
Experimental group 3 | 30 | 20 (66.7%) | 6 (20.0%) | 4 (13.3%) |
Experimental group 4 | 30 | 22 (73.3%) | 6 (20.0%) | 2 (6.7%) |
Experimental group 5 | 30 | 24 (80.0%) | 5 (16.7%) | 1 (3.3%) |
Experimental group 6 | 30 | 23 (76.7%) | 7 (23.3%) | 0 (0.0%) |
As seen from the above table, protein allergy tailored version clinical nutrition formula of the invention, compared to the commercially available anti-albumen of tradition
The full nutrient formulation of allergy, after intervening 3 months, total effective percentage is significantly improved.Be added to diet essence of the present invention and
Its effect of the experimental result of the experimental group of integration of drinking and medicinal herbs ingredient becomes apparent.
By above-described embodiment it is found that protein allergy tailored version clinical nutrition formula of the present invention can be according to egg
Clinical nutrition feature needed for white matter allergic human population provides balanced three major nutrient, also contains multivitamin and mineral
Matter provides high quality nutrition, enhances immune function;And using water such as depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumins
Solution formula milk gives EN support, prevents food protein allergy crowd from allergic reaction occurs.The medicine food that the present invention uses
There is the benefits of stomach strengthening and digestion promoting, enhancing body resistance against diseases, which improve conventional nutraceutical formulas often to make after homologous components compatibility synergy
Baby such as generates flatulence, is not easy to absorb at the digestive problems, peomotes the absorption of each nutriment in nutrient formulation, enhances baby
Constitution accelerates the growth and development of infant;There is Reduce allergy symptom after the diet essence compatibility synergy that the present invention uses, prevent
The benefits of inflammation, plays effective prevention and mitigation for the allergic symptom that protein allergy infant is likely to occur,
The body quality for improving baby contributes to the growth and development of baby.
Specific embodiments of the present invention are described in detail above, but it is intended only as example, the present invention is simultaneously unlimited
It is formed on particular embodiments described above.To those skilled in the art, it is any to the equivalent modifications that carry out of the present invention and
It substitutes also all among scope of the invention.Therefore, without departing from the spirit and scope of the invention made by impartial conversion and
Modification, all should be contained within the scope of the invention.
Claims (10)
1. a kind of protein allergy tailored version clinical nutrition formula, which is characterized in that including following component and its parts by weight:
15-21 parts of protein, 11-15 parts of fat, 52-57 parts of carbohydrate, 3.4-4.2 parts of dietary fibers, 1.2-1.8 parts of constant members
Element, 0.01-0.04 parts of trace elements, 0.005-0.02 parts of liposoluble vitamins, 0.1-0.3 parts of water soluble vitamins, 0.005-
0.11 part of nucleotide, 0.02-0.06 parts of natural plants compounds;
Wherein, in the nutrient formulation, protein:Fat:The productivity ratio of carbohydrate is 15~20:25~35:50~55;
Wherein, the protein includes amino acid and protein peptides;The amino acid includes taurine, and the protein peptides are selected from depth
Hydrolyzing lactoalbumin, appropriate hydrolyzing lactoalbumin, soy peptide powder, soybean oligopeptide, wheat protein peptide, pupa albumen peptide, ocean
At least one of fish oligopeptide powder, laughable peptide, amino peptide, ovalbumin peptide.
2. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that the albumen
Peptide includes at least one of depth hydrolysis' lactalbumin, appropriate hydrolyzing lactoalbumin, soy peptide powder.
3. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that the nutrition
In formula, protein:Fat:The productivity ratio of carbohydrate is 17:30:53.
4. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that the fat
In, the ratio of ω -6 unsaturated fatty acids and omega-3 unsaturated fatty acid is 3~6:1~2.
5. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that the fat
Including docosahexaenoic acid and arachidonic acid, weight ratio that the docosahexaenoic acid accounts for total fat is 1%~
2%, the weight ratio that the arachidonic acid accounts for total fat is 0.4%~2.4%.
6. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that the nucleosides
The parts by weight of acid are 0.11-1.2 parts.
7. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that further include
0.1-1 parts of integration of drinking and medicinal herbs ingredients, the integration of drinking and medicinal herbs ingredient are selected from hawthorn, the membrane of a chicken's gizzard, mulberries, matrimony vine, fructus alpiniae oxyphyllae, Chinese yam, Fu
At least one of Siberian cocklebur, malt, honey, jujube.
8. a kind of protein allergy tailored version clinical nutrition formula according to claim 1, which is characterized in that further include
0.1-1 parts of diet essence, the diet essence are selected from cereal, beans, potato, greengrocery, Homonemeae, nut-seed class, fishes and shrimps
At least one of class, poultry meat, fruits;Wherein, the greengrocery includes carrot meal, onion powder, garlic powder, cabbage
Powder, the Homonemeae include golden needle fungus, and the fruits include citrus powder, apple powder.
9. the preparation method of the protein allergy tailored version clinical nutrition formula according to any one of claim 1-8,
It is characterized in that, includes the following steps:
Step 1, powder fat is prepared;
Step 2, liposoluble vitamin powder and water soluble vitamin powder are prepared:By the liposoluble vitamin of predetermined weight number
It as core material, selects carragheen, Arabic gum as wall material, carries out 2 emulsifying homogeneous processing, emulsifying homogeneous time under high pressure
For 10~15min, instantaneous drying of spraying then is carried out, liposoluble vitamin powder is prepared with 60~80 mesh screenings;By predetermined weight
The water soluble vitamin of number is measured as core material, selects maltodextrin, lipoprotein as wall material, is uniformly mixed, spray instantaneous dry
It is dry, prepare water soluble vitamin powder with 60~80 mesh screenings;
Step 3, by the protein of predetermined weight and amino acid, nucleotide, carbohydrate, dietary fiber, macroelement, micro
Element, natural plants compound are prepared into the powder that grain size is 150~250 μm respectively;
Step 4, the powder obtained by step 1~3 is sequentially added into mixing machine and is uniformly mixed obtained formula mixture, by sterilization
It is spare after processing;
Step 5, the formula mixture is prepared into nutrient powder, nutrition emulsion, capsule, tablet, pill or oral solution
It is at least one;
Wherein, the sequence of step 1~3 can be replaced mutually.
10. preparation method according to claim 9, which is characterized in that prepare powder fat in the step 1 and specifically include
Following steps:
1) wall material aqueous solution is prepared:Take maltodextrin 273g, octenyl succinic acid starch 44g, lactalbumin 186g, dietary fiber
80g, water 1L are stirred evenly;
2) monoglyceride is taken into 1.17g (a concentration of 0.2%) of total solid is uniformly dissolved in 15.6mL mixed plant greases;It is described mixed
Vegetable fat is closed by 3mL olive oil, 6mL soybean oils, 3mL coconut oil, 0.8mL perilla herb oils, 2.5mL medium chain triglycerides, 0.2mL
Docosahexaenoic acid grease, 0.1mL arachidonic acid oils composition;
3) Tween 80 is taken into 1.17g (a concentration of 0.2%) of total solid is uniformly dissolved in the wall material aqueous solution;
4) the mixed plant grease and the wall material aqueous solution of addition Over emulsfication agent Tween 80 that add Over emulsfication agent monoglyceride is abundant
Mixing, obtains mixed solution;
5) (a concentration of 0.2%) of total solid is settled to after the mixed solution with water addition stabilizer agar 1.17g
(a concentration of 25%) of total solid, high speed dispersion 2 minutes, obtains emulsion to 200mL under 20000r/min;
6) by the emulsion at homogenization pressure 25MPa, homogeneous 3 times 5 minutes every time, obtains homogeneous emulsion;
7) the homogeneous emulsion is spray-dried, inlet air temperature is 195 DEG C, and leaving air temp is 80 DEG C, and collection obtains powder
Last fat.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810445032.0A CN108703365A (en) | 2018-05-10 | 2018-05-10 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810445032.0A CN108703365A (en) | 2018-05-10 | 2018-05-10 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108703365A true CN108703365A (en) | 2018-10-26 |
Family
ID=63867954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810445032.0A Pending CN108703365A (en) | 2018-05-10 | 2018-05-10 | Protein allergy tailored version clinical nutrition formula and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108703365A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110432482A (en) * | 2019-07-05 | 2019-11-12 | 上海奥医高科技实业有限公司 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
CN110558468A (en) * | 2019-10-21 | 2019-12-13 | 邓凡 | Modularized full-nutrition beverage formula without common allergens |
CN111657497A (en) * | 2020-06-28 | 2020-09-15 | 深圳市捷利康生物科技有限公司 | Ketogenic diet for resisting food protein allergy and preparation method thereof |
CN113729215A (en) * | 2021-08-30 | 2021-12-03 | 健康元药业集团股份有限公司 | Short peptide food emulsion and preparation method thereof |
CN117137130A (en) * | 2023-08-31 | 2023-12-01 | 东北农业大学 | Double-protein high-nutrition formula food preparation and preparation method and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
-
2018
- 2018-05-10 CN CN201810445032.0A patent/CN108703365A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106858620A (en) * | 2017-03-29 | 2017-06-20 | 上海奥医生物医药科技有限公司 | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof |
CN106962912A (en) * | 2017-03-29 | 2017-07-21 | 上海奥医生物医药科技有限公司 | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof |
CN106983136A (en) * | 2017-03-29 | 2017-07-28 | 上海奥医生物医药科技有限公司 | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof |
CN107242550A (en) * | 2017-06-29 | 2017-10-13 | 上海复旦奥医医学科技有限公司 | A kind of male sterility tailored version clinical nutrition formula and preparation method thereof |
CN107440120A (en) * | 2017-08-23 | 2017-12-08 | 上海奥医生物医药科技有限公司 | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof |
CN107616490A (en) * | 2017-08-23 | 2018-01-23 | 上海奥医生物医药科技有限公司 | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110432482A (en) * | 2019-07-05 | 2019-11-12 | 上海奥医高科技实业有限公司 | A kind of infant allergic dermatitis tailored version clinical nutrition formula and preparation method thereof |
CN110558468A (en) * | 2019-10-21 | 2019-12-13 | 邓凡 | Modularized full-nutrition beverage formula without common allergens |
CN111657497A (en) * | 2020-06-28 | 2020-09-15 | 深圳市捷利康生物科技有限公司 | Ketogenic diet for resisting food protein allergy and preparation method thereof |
CN113729215A (en) * | 2021-08-30 | 2021-12-03 | 健康元药业集团股份有限公司 | Short peptide food emulsion and preparation method thereof |
CN113729215B (en) * | 2021-08-30 | 2024-01-30 | 健康元药业集团股份有限公司 | Short peptide food emulsion and preparation method thereof |
CN117137130A (en) * | 2023-08-31 | 2023-12-01 | 东北农业大学 | Double-protein high-nutrition formula food preparation and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109645320A (en) | A kind of light jejunitas full nutrient formulation can brew instant stick and preparation method thereof | |
CN106983136A (en) | A kind of puerperium conditioning tailored version clinical nutrition formula and preparation method thereof | |
CN108703365A (en) | Protein allergy tailored version clinical nutrition formula and preparation method thereof | |
CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
CN106858620A (en) | A kind of anaemia tailored version clinical nutrition formula and preparation method thereof | |
CN106579393A (en) | Special clinical nutrient formula for diabetes and preparation method thereof | |
CN106962912A (en) | A kind of hepatopathy tailored version clinical nutrition formula and preparation method thereof | |
CN108651988A (en) | Nephrosis dialysis tailored version clinical nutrition formula and preparation method thereof | |
CN107440120A (en) | A kind of children's monophagia and anorexia tailored version clinical nutrition formula particular about food and preparation method thereof | |
CN107927754A (en) | Tailored version clinical nutrition formula and preparation method thereof is energized during one kind production | |
US20190335796A1 (en) | Optimized nutrient food | |
CN107440103A (en) | A kind of respiratory disease tailored version clinical nutrition formula and preparation method thereof | |
CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
CN106942748A (en) | A kind of female acyesis tailored version clinical nutrition formula and preparation method thereof | |
JP2021526821A (en) | Unchanged pea protein-based nutritional composition | |
CN108013454A (en) | Gynaecological imflammation tailored version clinical nutrition formula and preparation method thereof | |
CN108013453A (en) | Children's lactose intolerance tailored version clinical nutrition formula and preparation method thereof | |
CN108013452A (en) | A kind of puerperal abdominal flatulence gas tailored version clinical nutrition formula and preparation method thereof | |
CN107616490A (en) | A kind of postoperative tailored version clinical nutrition formula of children and preparation method thereof | |
CN107440121A (en) | A kind of Single Obesity tailored version clinical nutrition formula and preparation method thereof | |
CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
CN108669540A (en) | Cerebral apoplexy tailored version clinical nutrition formula and preparation method thereof | |
CN106858595A (en) | One kind burn tailored version clinical nutrition formula and preparation method thereof | |
CN107373672A (en) | A kind of irregular menstruation women tailored version clinical nutrition formula and preparation method thereof | |
CN108703364A (en) | Treating fatty acid metabolism tailored version clinical nutrition formula and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181026 |
|
RJ01 | Rejection of invention patent application after publication |